Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1974 2
1976 2
1980 1
1987 1
1988 1
1990 1
1999 1
2001 1
2002 1
2003 1
2004 3
2005 1
2009 2
2010 2
2011 1
2012 3
2013 2
2014 1
2015 2
2016 1
2017 3
2018 3
2019 3
2020 5
2021 8
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Management of immune-related adverse events and kinetics of response with ipilimumab.
Weber JS, Kähler KC, Hauschild A. Weber JS, et al. J Clin Oncol. 2012 Jul 20;30(21):2691-7. doi: 10.1200/JCO.2012.41.6750. Epub 2012 May 21. J Clin Oncol. 2012. PMID: 22614989 Review.
Monoclonal antibodies directed against the immune checkpoint protein cytotoxic T-lymphocyte antigen-4 (CTLA-4; CD152)-ipilimumab and tremelimumab-have been investigated in metastatic melanoma and other cancers and have shown promising results. Recently, ipilimumab was appr …
Monoclonal antibodies directed against the immune checkpoint protein cytotoxic T-lymphocyte antigen-4 (CTLA-4; CD152)-ipilimumab and tremeli …
Clinicopathological features and differential diagnosis of gastric metastases.
Chen W, Liu C, Liu Y, Yuan J, Wang Z. Chen W, et al. World J Surg Oncol. 2023 Aug 22;21(1):258. doi: 10.1186/s12957-023-03100-y. World J Surg Oncol. 2023. PMID: 37608278 Free PMC article.
In our study, the most common primary tumors were malignant melanoma (4 cases), small cell lung cancer (3 cases), and hepatocellular carcinoma (3 cases). Immunohistochemistry contributed to the pathological diagnosis and differential diagnosis of gastric metastases. Malign …
In our study, the most common primary tumors were malignant melanoma (4 cases), small cell lung cancer (3 cases), and hepatocellular …
Presentation, Management, and Prognosis of Primary Gastrointestinal Melanoma: A Population-Based Study.
Kahl AR, Gao X, Chioreso C, Goffredo P, Hassan I, Charlton ME, Lin C. Kahl AR, et al. J Surg Res. 2021 Apr;260:46-55. doi: 10.1016/j.jss.2020.11.048. Epub 2020 Dec 11. J Surg Res. 2021. PMID: 33316759 Free PMC article.

RESULTS: A total of 872 primary GI melanomas and 319,327 cutaneous melanomas were identified. GI melanoma incidence increased by an annual percent change of 1.82 (P < 0.05) during the study period. ...GI melanomas had significantly worse cancer-spec

…
RESULTS: A total of 872 primary GI melanomas and 319,327 cutaneous melanomas were identified. GI melanoma incidence inc …
Incretin-based therapies in the treatment of type 2 diabetes--more than meets the eye?
Labuzek K, Kozłowski M, Szkudłapski D, Sikorska P, Kozłowska M, Okopień B. Labuzek K, et al. Eur J Intern Med. 2013 Apr;24(3):207-12. doi: 10.1016/j.ejim.2013.01.009. Epub 2013 Jan 31. Eur J Intern Med. 2013. PMID: 23375875 Review.
A lot of contradictory data regarding the serious side effects of incretin-based therapies are currently available, with more being prepared or published every month. ...Therefore whenever such therapy is started it would be wise to proceed with caution, especially …
A lot of contradictory data regarding the serious side effects of incretin-based therapies are currently available, with more being p …
Clinical characteristics and treatment outcomes of primary malignant melanoma of esophagus: a single center experience.
Kim TS, Min BH, Min YW, Lee H, Rhee PL, Kim JJ, Lee JH. Kim TS, et al. BMC Gastroenterol. 2022 Mar 29;22(1):157. doi: 10.1186/s12876-022-02235-8. BMC Gastroenterol. 2022. PMID: 35351022 Free PMC article.
BACKGROUND: Primary malignant melanoma of esophagus (PMME) is an extremely rare disease with poor prognosis. ...
BACKGROUND: Primary malignant melanoma of esophagus (PMME) is an extremely rare disease with poor prognosis. ...
Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants.
Overbeek KA, Rodríguez-Girondo MD, Wagner A, van der Stoep N, van den Akker PC, Oosterwijk JC, van Os TA, van der Kolk LE, Vasen HFA, Hes FJ, Cahen DL, Bruno MJ, Potjer TP. Overbeek KA, et al. J Med Genet. 2021 Apr;58(4):264-269. doi: 10.1136/jmedgenet-2019-106562. Epub 2020 Jun 1. J Med Genet. 2021. PMID: 32482799 Free PMC article.
BACKGROUND: Pathogenic variants in the CDKN2A gene are generally associated with the development of melanoma and pancreatic ductal adenocarcinoma (PDAC), but specific genotype-phenotype correlations might exist and the extent of PDAC risk is not well established for many v …
BACKGROUND: Pathogenic variants in the CDKN2A gene are generally associated with the development of melanoma and pancreatic ductal ad …
Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
Sawka AM, Thabane L, Parlea L, Ibrahim-Zada I, Tsang RW, Brierley JD, Straus S, Ezzat S, Goldstein DP. Sawka AM, et al. Thyroid. 2009 May;19(5):451-7. doi: 10.1089/thy.2008.0392. Thyroid. 2009. PMID: 19281429 Review.
BACKGROUND: The risk of second primary malignancies (SPMs) associated with cancer therapies is an important concern of thyroid cancer survivors and physicians. ...We did not observe a significantly increased risk of the following cancers related to prior RAI treatment: bla …
BACKGROUND: The risk of second primary malignancies (SPMs) associated with cancer therapies is an important concern of thyroid cancer …
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility.
Kulkarni JA, Cullis PR, van der Meel R. Kulkarni JA, et al. Nucleic Acid Ther. 2018 Jun;28(3):146-157. doi: 10.1089/nat.2018.0721. Epub 2018 Apr 23. Nucleic Acid Ther. 2018. PMID: 29683383 Review.
Genetic drugs based on RNA or DNA have remarkable therapeutic potential as virtually any disease can be treated by silencing a pathological gene, expressing a beneficial protein, or by editing defective genes. However, therapies based on nucleic acid polymers requir …
Genetic drugs based on RNA or DNA have remarkable therapeutic potential as virtually any disease can be treated by silencing a pathol …
Oral cancer. The importance of early diagnosis and treatment.
Sciubba JJ. Sciubba JJ. Am J Clin Dermatol. 2001;2(4):239-51. doi: 10.2165/00128071-200102040-00005. Am J Clin Dermatol. 2001. PMID: 11705251 Review.
Mortality due to cancers in this region exceeds the annual death rate is the US caused by either cutaneous melanoma or cervical cancer. Significant agents involved in the etiology of oral cancer in Western countries include sunlight exposure, smoking and alcohol consumptio …
Mortality due to cancers in this region exceeds the annual death rate is the US caused by either cutaneous melanoma or cervical cance …
Malignant Melanoma of the Gastrointestinal Tract: Symptoms, Diagnosis, and Current Treatment Options.
Kohoutova D, Worku D, Aziz H, Teare J, Weir J, Larkin J. Kohoutova D, et al. Cells. 2021 Feb 5;10(2):327. doi: 10.3390/cells10020327. Cells. 2021. PMID: 33562484 Free PMC article. Review.
Malignant melanoma (MM) has become the fifth most frequent cancer in the UK. ...The complete surgical resection of GI metastatic MM in carefully selected patients not only provides symptom control, but has also been associated with an increase in overall survival. The appr …
Malignant melanoma (MM) has become the fifth most frequent cancer in the UK. ...The complete surgical resection of GI metastatic MM i …
51 results